Aurinia Pharmaceuticals 2024年第四季度GAAP每股收益$0.01超出$(0.02)的预期,销售额$59.87M低于$59.94M的预期

财报速递02-27
Aurinia Pharmaceuticals (NASDAQ:AUPH) 报告称季度每股收益为$0.01,超过了分析师一致预期的$(0.02),超出150%。 这比去年同期每股亏损$(0.19)增加了105.26%。 公司报告的季度销售额为$59.87百万,低于分析师一致预期的$59.94百万,差距为0.13%。 与去年同期$45.09百万的销售额相比,这增加了32.76%。

以上内容来自Benzinga Earnings专栏,原文如下:

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.02) by 150 percent. This is a 105.26 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $59.87 million which missed the analyst consensus estimate of $59.94 million by 0.13 percent. This is a 32.76 percent increase over sales of $45.09 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法